VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $12,995,000 | +835.6% | 72,851 | +1065.1% | 1.31% | +972.1% |
| Q2 2015 | $1,389,000 | +2.9% | 6,253 | -8.0% | 0.12% | 0.0% |
| Q1 2015 | $1,350,000 | +51.5% | 6,797 | +9.2% | 0.12% | +177.3% |
| Q4 2014 | $891,000 | +8.1% | 6,225 | -0.8% | 0.04% | +7.3% |
| Q3 2014 | $824,000 | -10.6% | 6,278 | -14.2% | 0.04% | -2.4% |
| Q2 2014 | $922,000 | -22.5% | 7,314 | -18.9% | 0.04% | -23.6% |
| Q1 2014 | $1,189,000 | +50.1% | 9,015 | +33.7% | 0.06% | +52.8% |
| Q4 2013 | $792,000 | +44.0% | 6,744 | +27.9% | 0.04% | +125.0% |
| Q3 2013 | $550,000 | +29.1% | 5,273 | +6.6% | 0.02% | -20.0% |
| Q2 2013 | $426,000 | +15.4% | 4,947 | +0.5% | 0.02% | +17.6% |
| Q1 2013 | $369,000 | – | 4,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |